PEACCEL
  • Home
  • About
    • PEACCEL at a glance
    • Management
    • Scientific Team
    • Publications
  • Technology
    • innov’SAR Platform
    • Computational Resources
  • Services
    • How PEACCEL Can Support You
    • Examples
  • News
  • Contact
  • PEACCEL
  • News
  • PEACCEL awarded by CIO Review
Jan 25 0

PEACCEL awarded by CIO Review

Posted by Webmaster

PEACCEL has just been nominated as most promising biotech solutions providers in Europe 2021.

Click the links below for more details:

HTML Link
Digital Magazine Link

  News  

Recent News

  • PEACCEL awarded by Wealth & Finance
  • PEACCEL awarded by CIO Review
  • PRAXISforum Enzymes for Industrial Applications 2020, 4-5 February 2020, Frankfurt, Germany
  • Protein Engineering Congress EU, 12-13 November 2019, Frankfurt am Main, Germany
  • Enzyme Engineering XXV, 15-19 September 2019, Whistler, British Columbia, Canada

Categories

  • News
  • Paper Highlights
  • Press Release

About PEACCEL

PEACCEL developed a unique and versatile AI-platform named innov’SAR that allows predicting multiple types of innovation in Life Sciences and biotechnology. PEACCEL provides solutions to make risky and investment intensive drug and enzyme development more efficient. Innovation cycles become with innov’SAR faster, more calculatable, and yield better results at lower costs compared to conventional methods.

Recent News

  • PEACCEL awarded by Wealth & Finance
  • PEACCEL awarded by CIO Review
  • PRAXISforum Enzymes for Industrial Applications 2020, 4-5 February 2020, Frankfurt, Germany

Search

Credits

  • Legal notice
  • Sitemap

© 2020 PEACCEL. All Rights Reserved.